Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cocaine | 22 | 2021 | 958 | 4.720 |
Why?
|
Self Administration | 24 | 2024 | 390 | 3.490 |
Why?
|
Macaca mulatta | 19 | 2024 | 2332 | 2.820 |
Why?
|
Methamphetamine | 8 | 2024 | 165 | 2.420 |
Why?
|
Central Nervous System Stimulants | 12 | 2024 | 1176 | 2.130 |
Why?
|
Nicotine | 8 | 2019 | 680 | 2.130 |
Why?
|
Conditioning, Operant | 18 | 2024 | 310 | 1.910 |
Why?
|
Saimiri | 5 | 2024 | 334 | 1.880 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 6 | 2024 | 415 | 1.660 |
Why?
|
Cocaine-Related Disorders | 8 | 2019 | 461 | 1.410 |
Why?
|
Narcotic Antagonists | 2 | 2024 | 585 | 1.340 |
Why?
|
Nucleus Accumbens | 2 | 2024 | 366 | 1.160 |
Why?
|
Benzazepines | 3 | 2018 | 310 | 1.140 |
Why?
|
Discrimination Learning | 4 | 2021 | 278 | 1.130 |
Why?
|
Drug-Seeking Behavior | 3 | 2024 | 46 | 1.120 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 3 | 2021 | 324 | 1.020 |
Why?
|
Naltrexone | 2 | 2024 | 317 | 0.980 |
Why?
|
Norepinephrine Plasma Membrane Transport Proteins | 2 | 2017 | 66 | 0.980 |
Why?
|
Alkaloids | 4 | 2021 | 192 | 0.980 |
Why?
|
Dose-Response Relationship, Drug | 21 | 2024 | 10766 | 0.960 |
Why?
|
Behavior, Animal | 8 | 2021 | 1878 | 0.910 |
Why?
|
Fentanyl | 2 | 2024 | 435 | 0.910 |
Why?
|
Food | 6 | 2019 | 772 | 0.880 |
Why?
|
Oxycodone | 1 | 2024 | 139 | 0.860 |
Why?
|
Dopamine Uptake Inhibitors | 7 | 2019 | 297 | 0.790 |
Why?
|
Reinforcement Schedule | 7 | 2021 | 123 | 0.730 |
Why?
|
Eating | 6 | 2019 | 1538 | 0.710 |
Why?
|
Saccharin | 3 | 2010 | 20 | 0.670 |
Why?
|
Wakefulness | 2 | 2024 | 1265 | 0.620 |
Why?
|
Choice Behavior | 3 | 2024 | 824 | 0.600 |
Why?
|
Heroin | 1 | 2018 | 119 | 0.600 |
Why?
|
Bupropion | 1 | 2019 | 304 | 0.590 |
Why?
|
Reward | 1 | 2024 | 971 | 0.560 |
Why?
|
Behavior, Addictive | 5 | 2019 | 462 | 0.550 |
Why?
|
Buspirone | 2 | 2013 | 81 | 0.510 |
Why?
|
Propiophenones | 2 | 2021 | 28 | 0.490 |
Why?
|
Animals | 45 | 2024 | 168441 | 0.480 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2015 | 186 | 0.470 |
Why?
|
Opioid-Related Disorders | 3 | 2024 | 2162 | 0.440 |
Why?
|
Anti-Anxiety Agents | 2 | 2013 | 397 | 0.430 |
Why?
|
Prefrontal Cortex | 1 | 2024 | 2218 | 0.430 |
Why?
|
Dopamine | 3 | 2017 | 1605 | 0.430 |
Why?
|
Clonidine | 1 | 2013 | 169 | 0.410 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2013 | 91 | 0.410 |
Why?
|
Recurrence | 1 | 2024 | 8469 | 0.390 |
Why?
|
Neural Pathways | 4 | 2024 | 3057 | 0.390 |
Why?
|
Magnetic Resonance Imaging | 6 | 2024 | 36423 | 0.390 |
Why?
|
Maternal Deprivation | 2 | 2008 | 48 | 0.380 |
Why?
|
Receptor, Serotonin, 5-HT2C | 4 | 2022 | 42 | 0.370 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 2 | 2021 | 65 | 0.360 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2020 | 3769 | 0.360 |
Why?
|
Primates | 3 | 2022 | 524 | 0.350 |
Why?
|
Serotonin | 3 | 2022 | 1042 | 0.320 |
Why?
|
Substance-Related Disorders | 3 | 2020 | 4420 | 0.310 |
Why?
|
Sweetening Agents | 2 | 2010 | 290 | 0.310 |
Why?
|
GABA Modulators | 1 | 2008 | 109 | 0.300 |
Why?
|
GABA Agonists | 1 | 2008 | 105 | 0.290 |
Why?
|
Lorazepam | 1 | 2008 | 154 | 0.280 |
Why?
|
Drinking Behavior | 1 | 2007 | 103 | 0.280 |
Why?
|
Ethanol | 2 | 2016 | 1324 | 0.270 |
Why?
|
Pyridazines | 1 | 2008 | 202 | 0.260 |
Why?
|
Male | 37 | 2024 | 360736 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2008 | 586 | 0.260 |
Why?
|
Periodicity | 1 | 2007 | 347 | 0.260 |
Why?
|
Rats | 12 | 2019 | 23742 | 0.260 |
Why?
|
Rats, Sprague-Dawley | 8 | 2024 | 8179 | 0.250 |
Why?
|
Rats, Long-Evans | 3 | 2012 | 383 | 0.250 |
Why?
|
Brain | 6 | 2024 | 27107 | 0.250 |
Why?
|
Nalbuphine | 1 | 2024 | 20 | 0.240 |
Why?
|
Flumazenil | 1 | 2024 | 84 | 0.240 |
Why?
|
Benzodioxoles | 2 | 2021 | 75 | 0.220 |
Why?
|
Receptors, GABA-A | 1 | 2008 | 623 | 0.220 |
Why?
|
Anesthetics, Local | 1 | 2010 | 997 | 0.210 |
Why?
|
Amphetamine-Related Disorders | 2 | 2024 | 80 | 0.210 |
Why?
|
Triazoles | 1 | 2008 | 903 | 0.200 |
Why?
|
Amphetamine | 2 | 2017 | 224 | 0.200 |
Why?
|
Pyrrolidines | 2 | 2021 | 338 | 0.200 |
Why?
|
Drug Interactions | 3 | 2016 | 1414 | 0.200 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 2 | 2022 | 31 | 0.200 |
Why?
|
Analgesics, Opioid | 3 | 2024 | 3804 | 0.200 |
Why?
|
Hypnotics and Sedatives | 2 | 2018 | 1179 | 0.190 |
Why?
|
Pyridines | 3 | 2016 | 2875 | 0.190 |
Why?
|
Limbic System | 1 | 2024 | 419 | 0.190 |
Why?
|
Pentanones | 1 | 2021 | 12 | 0.190 |
Why?
|
Feeding Behavior | 3 | 2016 | 3187 | 0.190 |
Why?
|
Isomerism | 1 | 2021 | 197 | 0.190 |
Why?
|
Nicotinic Agonists | 2 | 2013 | 265 | 0.190 |
Why?
|
Phosphocreatine | 1 | 2020 | 261 | 0.170 |
Why?
|
Rest | 1 | 2024 | 919 | 0.160 |
Why?
|
Choline | 1 | 2020 | 515 | 0.160 |
Why?
|
Creatine | 1 | 2020 | 427 | 0.160 |
Why?
|
Stereoisomerism | 1 | 2019 | 613 | 0.150 |
Why?
|
Aspartic Acid | 1 | 2020 | 576 | 0.150 |
Why?
|
Dextroamphetamine | 1 | 2018 | 134 | 0.150 |
Why?
|
Disulfiram | 1 | 2018 | 63 | 0.150 |
Why?
|
Infusions, Subcutaneous | 1 | 2017 | 43 | 0.150 |
Why?
|
Acetylcysteine | 1 | 2019 | 260 | 0.150 |
Why?
|
Corpus Striatum | 1 | 2024 | 1235 | 0.140 |
Why?
|
Brain Mapping | 2 | 2024 | 6626 | 0.140 |
Why?
|
Behavioral Symptoms | 1 | 2018 | 186 | 0.130 |
Why?
|
Stress, Psychological | 1 | 2012 | 4477 | 0.130 |
Why?
|
Injections, Intramuscular | 1 | 2017 | 554 | 0.130 |
Why?
|
Psychotropic Drugs | 1 | 2021 | 888 | 0.130 |
Why?
|
Glutamic Acid | 1 | 2020 | 1176 | 0.120 |
Why?
|
Random Allocation | 1 | 2019 | 2394 | 0.120 |
Why?
|
Norepinephrine | 1 | 2017 | 897 | 0.120 |
Why?
|
Cannabidiol | 1 | 2016 | 118 | 0.120 |
Why?
|
Psychomotor Performance | 2 | 2016 | 1879 | 0.120 |
Why?
|
Methylphenidate | 1 | 2018 | 488 | 0.120 |
Why?
|
Gyrus Cinguli | 1 | 2020 | 1115 | 0.120 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2020 | 1140 | 0.120 |
Why?
|
Antipsychotic Agents | 2 | 2022 | 3068 | 0.110 |
Why?
|
Benztropine | 1 | 2013 | 17 | 0.110 |
Why?
|
Microdialysis | 1 | 2014 | 161 | 0.110 |
Why?
|
Female | 15 | 2024 | 392581 | 0.110 |
Why?
|
Autoantigens | 1 | 2017 | 892 | 0.110 |
Why?
|
Arousal | 1 | 2018 | 1166 | 0.100 |
Why?
|
Reaction Time | 1 | 2018 | 2080 | 0.100 |
Why?
|
Psychology | 1 | 2014 | 356 | 0.100 |
Why?
|
Nerve Net | 1 | 2024 | 2288 | 0.100 |
Why?
|
Membrane Transport Proteins | 1 | 2017 | 1035 | 0.100 |
Why?
|
Quinoxalines | 1 | 2013 | 296 | 0.100 |
Why?
|
Receptors, sigma | 1 | 2011 | 45 | 0.090 |
Why?
|
Taste | 2 | 2010 | 189 | 0.090 |
Why?
|
Oxalates | 1 | 2011 | 98 | 0.090 |
Why?
|
Corticosterone | 1 | 2012 | 305 | 0.090 |
Why?
|
Diffusion Tensor Imaging | 1 | 2020 | 2399 | 0.090 |
Why?
|
Carbazoles | 1 | 2011 | 220 | 0.090 |
Why?
|
Catheterization, Peripheral | 1 | 2013 | 342 | 0.080 |
Why?
|
Aging | 1 | 2008 | 8705 | 0.080 |
Why?
|
Motor Activity | 2 | 2017 | 2711 | 0.080 |
Why?
|
Cues | 2 | 2012 | 875 | 0.080 |
Why?
|
Avoidance Learning | 2 | 2007 | 248 | 0.080 |
Why?
|
Mice, Knockout | 1 | 2024 | 14409 | 0.080 |
Why?
|
Genes, fos | 1 | 2008 | 176 | 0.080 |
Why?
|
Protein Binding | 1 | 2021 | 9352 | 0.080 |
Why?
|
Genes, Immediate-Early | 1 | 2008 | 102 | 0.080 |
Why?
|
Tobacco Use Disorder | 1 | 2013 | 703 | 0.070 |
Why?
|
Sex Characteristics | 2 | 2008 | 2637 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2010 | 6231 | 0.070 |
Why?
|
Protein Conformation | 1 | 2014 | 3969 | 0.070 |
Why?
|
Dopamine Agonists | 1 | 2008 | 352 | 0.070 |
Why?
|
Ataxia | 1 | 2008 | 306 | 0.060 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22163 | 0.060 |
Why?
|
Serotonin Antagonists | 1 | 2005 | 145 | 0.060 |
Why?
|
Cognition | 2 | 2019 | 6986 | 0.060 |
Why?
|
Piperidines | 1 | 2011 | 1656 | 0.050 |
Why?
|
Receptor, Serotonin, 5-HT2A | 1 | 2022 | 64 | 0.050 |
Why?
|
Tetrahydronaphthalenes | 1 | 2022 | 86 | 0.050 |
Why?
|
Extinction, Psychological | 2 | 2019 | 371 | 0.050 |
Why?
|
Adaptation, Physiological | 1 | 2007 | 1301 | 0.040 |
Why?
|
Time Factors | 3 | 2013 | 39975 | 0.040 |
Why?
|
Pyrazines | 1 | 2005 | 1201 | 0.040 |
Why?
|
Pentobarbital | 1 | 2018 | 153 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2018 | 18247 | 0.040 |
Why?
|
Free Radical Scavengers | 1 | 2019 | 211 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2691 | 0.040 |
Why?
|
Rats, Inbred F344 | 2 | 2009 | 826 | 0.040 |
Why?
|
Rats, Inbred Lew | 2 | 2009 | 1157 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2018 | 64651 | 0.030 |
Why?
|
Neurotransmitter Agents | 1 | 2019 | 665 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 4852 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11073 | 0.030 |
Why?
|
Piperazines | 1 | 2005 | 2523 | 0.030 |
Why?
|
Species Specificity | 2 | 2009 | 2416 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 832 | 0.030 |
Why?
|
Photic Stimulation | 1 | 2019 | 1985 | 0.030 |
Why?
|
Anisoles | 1 | 2011 | 6 | 0.020 |
Why?
|
Mice | 4 | 2024 | 81509 | 0.020 |
Why?
|
Radioligand Assay | 1 | 2011 | 366 | 0.020 |
Why?
|
Propylamines | 1 | 2011 | 161 | 0.020 |
Why?
|
Antazoline | 1 | 2009 | 6 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2013 | 1334 | 0.020 |
Why?
|
Humans | 4 | 2024 | 761423 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9418 | 0.020 |
Why?
|
History, 20th Century | 1 | 2014 | 2769 | 0.020 |
Why?
|
Lysergic Acid Diethylamide | 1 | 2005 | 47 | 0.020 |
Why?
|
Mianserin | 1 | 2005 | 51 | 0.020 |
Why?
|
Lithium Chloride | 1 | 2005 | 82 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2009 | 1847 | 0.020 |
Why?
|
Neurons | 1 | 2024 | 9462 | 0.010 |
Why?
|
Motivation | 1 | 2013 | 2006 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2007 | 2677 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2811 | 0.010 |
Why?
|
United States | 1 | 2014 | 72339 | 0.000 |
Why?
|
Concepts
(185)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_